Bone Density Conservation Agents; Humans; Aged; World Health Organization; Bone Density Conservation Agents/therapeutic use; Hip Fractures/therapy; Hip Fractures/surgery; Osteoporosis/therapy; Osteoporosis/complications; Osteoporosis/drug therapy; Osteoporotic Fractures/therapy; Osteoporotic Fractures/prevention & control; Benchmarking; Health Equity; Hip Fractures; Osteoporosis; Osteoporotic Fractures; Rheumatology
Abstract :
[en] Hip fractures cause major morbidity, mortality and long-term disability among older persons worldwide. The World Health Organization has defined two key indicators within the framework of the UN Decade of Healthy Ageing to measure health system performance in providing care for older adults with hip fractures: the proportion who receive surgery within 48 h of fracture; and the proportion who receive pharmacological treatment for osteoporosis post-fracture. This Perspective article, which describes the clinical importance of these indicators, their amenability for adoption and implications for health equity, is based on findings from audits, guidelines and key literature. Numerous evidence-based solutions - for example, fracture liaison services, orhtogeriatric care models and digital tools support hip-fracture management, yet major barriers remain, such as data gaps, system preparedness and pathway variability. New or modified policies developed by national governments, ministries of health and other relevant authorities and tailored to specific geopolitical contexts are urgently needed to enable the implementation of timely surgical care and secondary fracture prevention strategies aligned with the WHO indicators. Improved health information systems to measure performance and to ensure translation to real-world changes in the lives of older people worldwide are of paramount importance.
Disciplines :
Public health, health care sciences & services
Author, co-author :
Chandran, Manju ; Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, Singapore, Singapore ; DUKE NUS Medical School, Singapore, Singapore ; WHO Collaborating Centre for Epidemiology of Musculoskeletal Health and Aging, Liège, Belgium
Thiyagarajan, Jotheeswaran A; Ageing and Health Unit, Department of Maternal, Newborn, Child, Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland. amuthavallithiya@who.int
Alokail, Majed; WHO Collaborating Centre for Epidemiology of Musculoskeletal Health and Aging, Liège, Belgium ; Protein Research Chair, Biochemistry Dept, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé ; WHO Collaborating Centre for Epidemiology of Musculoskeletal Health and Aging, Liège, Belgium
Harvey, Nicholas C ; WHO Collaborating Centre for Epidemiology of Musculoskeletal Health and Aging, Liège, Belgium ; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK
Rizzoli, René ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé ; WHO Collaborating Centre for Epidemiology of Musculoskeletal Health and Aging, Liège, Belgium ; Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
Veronese, Nicola ; WHO Collaborating Centre for Epidemiology of Musculoskeletal Health and Aging, Liège, Belgium ; Uni Camillus International University of Health Sciences, Rome, Italy ; Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique ; WHO Collaborating Centre for Epidemiology of Musculoskeletal Health and Aging, Liège, Belgium ; Protein Research Chair, Biochemistry Dept, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia
Language :
English
Title :
WHO benchmarks for equitable hip-fracture care and osteoporosis treatment in older people.
World Health Organization. Measuring the Progress and Impact of the UN Decade of Healthy Ageing (2021–2030): Framework and Indicators Recommended by WHO Technical Advisory Group (2024).
Chandran M et al. The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options Arch. Osteoporos. 2019 14 31773442 10.1007/s11657-019-0664-4 114
Muschitz C et al. Epidemiology and economic burden of fragility fractures in Austria Osteoporos. Int. 2022 33 637 647 34622302 10.1007/s00198-021-06152-6 1:STN:280:DC%2BB2cnnsFeqtg%3D%3D
Borgström F et al. Fragility fractures in Europe: burden, management and opportunities Arch. Osteoporos. 2020 15 32306163 7166207 10.1007/s11657-020-0706-y 59
Mohd-Tahir N-A Li S-C Economic burden of osteoporosis-related hip fracture in Asia: a systematic review Osteoporos. Int. 2017 28 2035 2044 28314898 10.1007/s00198-017-3985-4
Australia and New Zealand Hip Fracture Registry. ANZHFR 2022 Annual Report Full e-Report https://anzhfr.org/registry-reports/# (2022).
Dyer SM et al. A critical review of the long-term disability outcomes following hip fracture BMC Geriatr. 2016 16 158 27590604 5010762 10.1186/s12877-016-0332-0
Moerman S Mathijssen NM Tuinebreijer WE Nelissen RG Vochteloo AJ Less than one-third of hip fracture patients return to their prefracture level of instrumental activities of daily living in a prospective cohort study of 480 patients Geriatr. Gerontol. Int. 2018 18 1244 1248 30004174 10.1111/ggi.13471
Harvey LA et al. Variation in mortality following hip fracture across the Asia Pacific region: systematic review and proportional meta-analysis Arch. Gerontol. Geriatr. 2024 126 38941947 10.1016/j.archger.2024.105519 1:STN:280:DC%2BB1cbosVKlsg%3D%3D 105519
Jayasekera PT et al. Hip fractures and outcome in elderly patients in a tertiary care hospital of Sri Lanka Arch. Osteoporos. 2023 18 37672198 10.1007/s11657-023-01323-w 113
Kanis JA Cooper C Rizzoli R Reginster J-Y Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF) European guidance for the diagnosis and management of osteoporosis in postmenopausal women Osteoporos. Int. 2019 30 3 44 30324412 10.1007/s00198-018-4704-5 1:STN:280:DC%2BB3czps1KrsQ%3D%3D
Australian Institute of Health and Welfare. Hip fracture care clinical care standard indicators: 4a-Proportion of patients with a hip fracture receiving surgery within 48 hours of presentation with the hip fracture. METEOR identifier 628088 https://meteor.aihw.gov.au/content/628088 (2016).
Australian and New Zealand Hip Fracture Registry. ANZHFR User Guide Data Dictionary v17, January 2025 https://go.nature.com/3X9ynYa (2025).
Canadian Institute for Health Information. Hip Fracture Surgery within 48 Hours; https://go.nature.com/3LsaxnY (2025).
Pincus D et al. Association between wait time and 30-day mortality in adults undergoing hip fracture surgery JAMA 2017 318 1994 2003 29183076 5820694 10.1001/jama.2017.17606
Sobolev B et al. Mortality effects of timing alternatives for hip fracture surgery CMAJ 2018 190 E923 E932 30087128 6078777 10.1503/cmaj.171512
HIP ATTACK Investigators Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial Lancet 2020 395 698 708 10.1016/S0140-6736(20)30058-1
Klestil T et al. Impact of timing of surgery in elderly hip fracture patients: a systematic review and meta-analysis Sci. Rep. 2018 8 30224765 6141544 10.1038/s41598-018-32098-7 13933
Darbandi AD et al. Effects of delayed hip fracture surgery on severely ill patients: defining the time to medical optimization Am. Surg. 2023 89 1864 1871 35324321 10.1177/00031348221080425
Ricci WM Brandt A McAndrew C Gardner MJ Factors affecting delay to surgery and length of stay for patients with hip fracture J. Orthop. Trauma. 2015 29 e109 e114 25186844 4339640 10.1097/BOT.0000000000000221
Cohen-Mansfield J et al. The old, old-old, and the oldest old: continuation or distinct categories? An examination of the relationship between age and changes in health, function, and wellbeing Int. J. Aging Hum. Dev. 2013 77 37 57 23986979 10.2190/AG.77.1.c
Prestmo A et al. Comprehensive geriatric care for patients with hip fractures: a prospective, randomised, controlled trial Lancet 2015 385 1623 1633 25662415 10.1016/S0140-6736(14)62409-0
Van Heghe A et al. Effects of orthogeriatric care models on outcomes of hip fracture patients: a systematic review and meta-analysis Calcif. Tissue Int. 2022 110 162 184 34591127 10.1007/s00223-021-00913-5
Mazarello Paes V et al. Which performance indicators are used globally for evaluating healthcare in patients with a hip fracture? Bone Jt Open. 2025 6 275 290 40043739 11882308 10.1302/2633-1462.63.BJO-2024-0104.R1
National Institute for Health and Care Excellence. Hip Fracture: Management https://www.nice.org.uk/guidance/cg124 (22 June 2011).
Australian Commission on Safety and Quality in Health Care. Hip Fracture Clinical Care Standardhttps://go.nature.com/3JfAuXq (2023).
Weil YA et al. Hip fracture care and national systems in Israel and South Africa OTA Int. 2020 3 33842858 8016509 10.1097/OI9.0000000000000065 e065
Public Health Scotland. Scottish Hip Fracture Audit: Reporting on 2023; https://go.nature.com/4hJ6eRs (2024).
Eardley W Johansen A The national hip fracture database: lessons learned and future horizons Orthop. Trauma. 2024 38 108 113 10.1016/j.mporth.2024.01.007
Arshi A Rezzadeh K Stavrakis AI Bukata SV Zeegen EN Standardized hospital-based care programs improve geriatric hip fracture outcomes: an analysis of the ACS NSQIP Targeted Hip Fracture Series J. Orthop. Trauma. 2019 33 e223 e228 30702503 10.1097/BOT.0000000000001443
American College of Surgeons. Performance Improvement in a Hip Fracture ERAS Program. https://www.facs.org/quality-programs/qi-resources/case-studies/performance-improvement-in-a-hip-fracture-eras-program/.
Kiani SN et al. Hip fracture surgery in resource-limited environments: a systematic literature review OTA Int. 2025 8 39886105 11781767 10.1097/OI9.0000000000000373 e373
Jain D et al. Early results of a geriatric hip fracture program in India for femoral neck fracture Geriatr. Orthop. Surg. Rehabil. 2015 6 42 46 26246953 4318811 10.1177/2151458514567314
Kanis JA et al. A systematic review of the worldwide incidence and mortality of hip fracture Osteoporos. Int. 2012 23 2239 2256 22419370 3421108 10.1007/s00198-012-1964-3 1:STN:280:DC%2BC38vmvVCksw%3D%3D
Edwards BJ Bunta AD Simonelli C Bolander M Fitzpatrick LA Prior fractures are common in patients with subsequent hip fractures Clin. Orthop. Relat. Res. 2007 461 226 230 17415014 10.1097/BLO.0b013e3180534269
Port L et al. Osteoporotic fracture: missed opportunity for intervention Osteoporos. Int. 2003 14 780 784 12904835 10.1007/s00198-003-1452-x
Song X et al. Cost burden of second fracture in the US health system Bone 2011 48 828 836 21211578 10.1016/j.bone.2010.12.021
Chandran M Akesson K Secondary fracture prevention: plucking the low hanging fruit Ann. Acad. Med. Singap. 2013 42 541 544 24254243 10.47102/annals-acadmedsg.V42N10p541
Palacios S et al. Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis Climacteric 2015 18 805 812 26029985 10.3109/13697137.2015.1045484 1:CAS:528:DC%2BC2MXhvFWqurrL
Saito T et al. Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis Osteoporos. Int. 2017 28 3289 3300 28770272 10.1007/s00198-017-4175-0 1:CAS:528:DC%2BC2sXht1OjsrfM
Lyles KW et al. Zoledronic acid and clinical fractures and mortality after hip fracture N. Engl. J. Med. 2007 357 1799 1809 17878149 10.1056/NEJMoa074941 1:CAS:528:DC%2BD2sXht1Kit7nN
Sing C-W et al. Global epidemiology of hip fractures: secular trends in incidence rate, post-fracture treatment, and all-cause mortality J. Bone Miner. Res. 2023 38 1064 1075 37118993 10.1002/jbmr.4821
Mohsin Z Javaid MK Johansen A Current approaches to secondary prevention after hip fracture in England and Wales — an analysis of trends between 2016 and 2020 using the national hip fracture database (NHFD) Arch. Osteoporos. 2023 18 37428295 10333382 10.1007/s11657-023-01282-2 93
Osteoporosis Canada. Facts and Stats; https://osteoporosis.ca/facts-and-stats/ (2019).
International Osteoporosis Foundation. Major Milestone for Secondary Fracture Prevention Announced in Japan; https://go.nature.com/4hLhZ9Z (2022).
Camacho PM et al. American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis — 2020 update Endocr. Pract. 2020 26 1 46 32427503 10.4158/GL-2020-0524SUPPL
Eastell R et al. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline J. Clin. Endocrinol. Metab. 2019 104 1595 1622 30907953 10.1210/jc.2019-00221
Gregson CL et al. UK clinical guideline for the prevention and treatment of osteoporosis Arch. Osteoporos. 2022 17 35378630 8979902 10.1007/s11657-022-01061-5 58
Chandran M Cheen M Ying H Lau TC Tan M Dropping the ball and falling off the care wagon. Factors correlating with nonadherence to secondary fracture prevention programs J. Clin. Densitom. 2016 19 117 124 26209018 10.1016/j.jocd.2015.06.009
Bennett MJ Center JR Perry L Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study Osteoporos. Int. 2023 34 1249 1262 37093239 10281902 10.1007/s00198-023-06748-0
Cho C Bak G Sumpton D Richards B Sherrington C Perspectives of healthcare providers on osteoporosis, falls and fracture risk: a systematic review and thematic synthesis of qualitative studies Arch. Osteoporos. 2024 19 39313605 11420259 10.1007/s11657-024-01446-8 90
Muzzammil M Owais Minhas M Jamil A Closing the gap: addressing health disparities in the management of fragility fractures in low and middle-income countries’ geriatric population J. Orthop. Rep. 2025 4 100468 10.1016/j.jorep.2024.100468
Ruggiero C et al. The interdisciplinary fracture liaison service improves health-related outcomes and survival of older adults after hip fracture surgical repair Arch. Osteoporos. 2022 17 36251126 9576663 10.1007/s11657-022-01171-0 135
Chandran M et al. Secondary prevention of osteoporotic fractures — an “OPTIMAL” model of care from Singapore Osteoporos. Int. 2013 24 2809 2817 23615816 10.1007/s00198-013-2368-8 1:STN:280:DC%2BC3srotVyqsg%3D%3D
Kim MS et al. The impact of a fracture liaison service for patients with femoral fractures on subsequent fractures and mortality: focusing on systematic literature review and metaanalysis Arch. Osteoporos. 2025 20 39955675 10.1007/s11657-025-01505-8 1:CAS:528:DC%2BB2MXlsVyrtLs%3D 24
Javaid MK Efficacy and efficiency of fracture liaison services to reduce the risk of recurrent osteoporotic fractures Aging Clin. Exp. Res. 2021 33 2061 2067 34047929 8302543 10.1007/s40520-021-01844-9 1:STN:280:DC%2BB2c7gt1GrtA%3D%3D
Xu L et al. Return on investment of fracture liaison services: a systematic review and analysis Osteoporos. Int. 2024 35 951 969 38300316 10.1007/s00198-024-07027-2 1:STN:280:DC%2BB1czksVOnsw%3D%3D
Pinedo-Villanueva R Burn E Maronga C Cooper C Javaid MK Expected benefits and budget impact from a microsimulation model support the prioritization and implementation of fracture liaison services J. Bone Miner. Res. 2023 38 499 511 36662166 10.1002/jbmr.4775
Cooper MS Palmer AJ Seibel MJ Cost-effectiveness of the concord minimal trauma fracture liaison service, a prospective, controlled fracture prevention study Osteoporos. Int. 2012 23 97 107 21953475 10.1007/s00198-011-1802-z 1:STN:280:DC%2BC387gvVCgsw%3D%3D
Moriwaki K Noto S Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan Osteoporos. Int. 2017 28 621 632 27699441 10.1007/s00198-016-3777-2 1:STN:280:DC%2BC2svmsVeksw%3D%3D
Mitchell P et al. Implementation of Models of Care for secondary osteoporotic fracture prevention and orthogeriatric models of care for osteoporotic hip fracture Best. Pract. Res. Clin. Rheumatol. 2016 30 536 558 27886945 10.1016/j.berh.2016.09.008
Curtis J Silverman SL Commentary: the five Ws of a Fracture Liaison Service: Why, Who, What, Where and How? In osteoporosis, we reap what we sow Curr. Osteoporos. Rep. 2013 11 365 368 24104520 10.1007/s11914-013-0177-9
Cheah MH Lai PSM Ong T Views of healthcare professionals regarding barriers and facilitators for a Fracture Liaison Service in Malaysia PLoS ONE 2024 19 39058713 11280531 10.1371/journal.pone.0307919 1:CAS:528:DC%2BB2cXitFGgsL7F e0307919
Maldar A Chadha M Fracture liaison services in India: challenges and opportunities J. Assoc. Physicians India 2023 71 11 13 38736047 10.59556/japi.71.0423
Wang C-C Liu H-C Lee M-T Huang W-T Effects of fracture liaison service on outcomes of patients with hip fracture in rural area of an Asian country Geriatr. Orthop. Surg. Rehabil. 2023 14 21514593231204783 37767222 10521283 10.1177/21514593231204783
Chandran M et al. Development of the Asia Pacific Consortium on Osteoporosis (APCO) framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region Osteoporos. Int. 2021 32 1249 1275 33502559 8192320 10.1007/s00198-020-05742-0 1:STN:280:DC%2BB3srlvFSktg%3D%3D
Dreinhöfer KE et al. A global call to action to improve the care of people with fragility fractures Injury 2018 49 1393 1397 29983172 10.1016/j.injury.2018.06.032
Fujii T Mori T Komiyama J Kuroda N Tamiya N Factors associated with non-initiation of osteoporosis pharmacotherapy after hip fracture: analysis of claims data in Japan Arch. Osteoporos. 2023 18 37477723 10361872 10.1007/s11657-023-01314-x 103
Royal College of Physicians. 15 Years of Quality Improvement: the 2023 National Hip Fracture Database Annual Report on 2022; https://www.nhfd.co.uk/2023report (2023).